Bone Morphogenetic Protein Receptor 1A (BMPR1A) Peptide
BMPR1A
Reactivité: Humain, Souris, Rat, Mouton
Hôte: Synthetic
BP
-
- Antigène Tous les produits BMPR1A
- BMPR1A (Bone Morphogenetic Protein Receptor 1A (BMPR1A))
- Origine
- Humain, Souris, Rat, Mouton
-
Source
- Synthetic
- Application
- Blocking Peptide (BP)
- Attributs du produit
- The peptide is used to block Anti-CD292 Antibody reactivity.
-
Bone Morphogenetic Protein Receptor 1A (BMPR1A) peptide
BMPR1A Reactivité: Humain, Chien Hôte: Synthetic BP, Imm
-
- Indications d'application
- Blocking Peptide to the diluted primary antibody in a molar ratio of 10:1 (peptide to antibody) and incubate the mixture at 4 °C for overnight or at room temperature for 2 hours.
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Stock
- -20 °C
- Stockage commentaire
- Shipped at 4°C. Store at -20°C for one year.
- Date de péremption
- 12 months
-
- Antigène
- BMPR1A (Bone Morphogenetic Protein Receptor 1A (BMPR1A))
- Synonymes
- 10q23del Peptide, ACVRLK3 Peptide, ALK3 Peptide, CD292 Peptide, SKR5 Peptide, 1110037I22Rik Peptide, AU045487 Peptide, BMPR-IA Peptide, Bmpr Peptide, BMPR-1 Peptide, BRK-1 Peptide, BMPR1A Peptide, acvrlk3 Peptide, alk-3 Peptide, alk3 Peptide, cd292 Peptide, skr5 Peptide, BR1a Peptide, alk3tr Peptide, bmpr1a Peptide, zgc:136731 Peptide, wu:fe05b06 Peptide, wu:fe06e10 Peptide, zgc:92227 Peptide, bone morphogenetic protein receptor type 1A Peptide, bone morphogenetic protein receptor, type 1A Peptide, bone morphogenetic protein receptor type 1A S homeolog Peptide, bone morphogenetic protein receptor, type IAa Peptide, bone morphogenetic protein receptor, type IAb Peptide, BMPR1A Peptide, Bmpr1a Peptide, bmpr1a Peptide, bmpr1a.S Peptide, bmpr1aa Peptide, bmpr1ab Peptide
- Sujet
- ACVRLK3, ALK3, Bone morphogenetic protein receptor type-1A, BMP type-1A receptor, BMPR-1A, Activin receptor-like kinase 3, ALK-3, Serine/threonine-protein kinase receptor R5, SKR5, CD292
- ID gène
- 657, 12166, 81507
- UniProt
- P36894, P36895, Q78EA7
-
Vous êtes ici:
